1. Home
  2. ZLAB vs ITGR Comparison

ZLAB vs ITGR Comparison

Compare ZLAB & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • ITGR
  • Stock Information
  • Founded
  • ZLAB 2013
  • ITGR 1970
  • Country
  • ZLAB China
  • ITGR United States
  • Employees
  • ZLAB N/A
  • ITGR N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ZLAB Health Care
  • ITGR Health Care
  • Exchange
  • ZLAB Nasdaq
  • ITGR Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • ITGR 4.2B
  • IPO Year
  • ZLAB 2017
  • ITGR 2000
  • Fundamental
  • Price
  • ZLAB $32.54
  • ITGR $119.95
  • Analyst Decision
  • ZLAB Buy
  • ITGR Strong Buy
  • Analyst Count
  • ZLAB 5
  • ITGR 10
  • Target Price
  • ZLAB $54.28
  • ITGR $145.90
  • AVG Volume (30 Days)
  • ZLAB 782.4K
  • ITGR 448.0K
  • Earning Date
  • ZLAB 08-05-2025
  • ITGR 07-24-2025
  • Dividend Yield
  • ZLAB N/A
  • ITGR N/A
  • EPS Growth
  • ZLAB N/A
  • ITGR N/A
  • EPS
  • ZLAB N/A
  • ITGR 2.18
  • Revenue
  • ZLAB $418,326,000.00
  • ITGR $1,746,192,000.00
  • Revenue This Year
  • ZLAB $44.07
  • ITGR $11.03
  • Revenue Next Year
  • ZLAB $49.13
  • ITGR $7.29
  • P/E Ratio
  • ZLAB N/A
  • ITGR $54.29
  • Revenue Growth
  • ZLAB 43.72
  • ITGR 10.19
  • 52 Week Low
  • ZLAB $16.01
  • ITGR $104.93
  • 52 Week High
  • ZLAB $44.34
  • ITGR $146.36
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • ITGR 49.25
  • Support Level
  • ZLAB $34.26
  • ITGR $116.25
  • Resistance Level
  • ZLAB $35.72
  • ITGR $122.99
  • Average True Range (ATR)
  • ZLAB 1.12
  • ITGR 2.44
  • MACD
  • ZLAB -0.54
  • ITGR -0.04
  • Stochastic Oscillator
  • ZLAB 3.83
  • ITGR 49.80

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

Share on Social Networks: